Literature DB >> 25765157

Sensorimotor skills in Fxn KO/Mck mutants deficient for frataxin in muscle.

Mohammed Filali1, Robert Lalonde2, Catherine Gérard3, Zoé Coulombe3, Jacques P Tremblay3.   

Abstract

Friedreich ataxia is the most common autosomal recessive disorder of the cerebellum, causing degeneration of spinal sensory neurons and spinocerebellar tracts. The disease is caused by severely reduced levels of frataxin, a mitochondrial protein involved in iron metabolism. An experimental model has been generated by crossing mice homozygous for a conditional allele of the Fxn gene with mice heterozygous for a deleted exon 4 of Fxn carrying a tissue-specific Cre transgene under control of the muscle creatine kinase promoter. Relative to wild-type, Fxn null mutants were impaired on tests of motor coordination comprising horizontal bar, vertical pole, and the rotorod as well as displaying gait anomalies and the hindlimb clasping response. The Fxn KO/Mck model reproduces some key features of patients with Friedreich ataxia and provides an opportunity of ameliorating their symptoms with experimental therapies.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ataxic models; Hindlimb clasping; Hot-plate; Motor activity; Motor coordination; Rotorod; Sensorimotor systems

Mesh:

Substances:

Year:  2015        PMID: 25765157     DOI: 10.1016/j.brainres.2015.03.001

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  Neurobehavioral deficits in the KIKO mouse model of Friedreich's ataxia.

Authors:  Marissa Z McMackin; Chelsea K Henderson; Gino A Cortopassi
Journal:  Behav Brain Res       Date:  2016-08-26       Impact factor: 3.332

2.  Characterization of motor function in mice developmentally exposed to ethanol using the Catwalk system: Comparison with the triple horizontal bar and rotarod tests.

Authors:  Belkis Jacquez; Hyesun Choi; Clark W Bird; David N Linsenbardt; C Fernando Valenzuela
Journal:  Behav Brain Res       Date:  2020-08-26       Impact factor: 3.332

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.